BSE Live
Apr 06, 16:01Prev. Close
67.71
Open Price
71.99
Bid Price (Qty.)
63.50 (500)
Offer Price (Qty.)
70.00 (123)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Relic Life Science (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 0.12 | -3.89 | 0.16 | 0.04 | -0.17 | |
| Diluted EPS (Rs.) | 0.12 | -3.89 | 0.16 | 0.04 | -0.17 | |
| Cash EPS (Rs.) | 0.49 | 0.18 | 0.46 | 0.34 | 0.10 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 11.16 | 11.04 | 11.13 | 10.97 | 10.92 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 11.16 | 11.04 | 11.13 | 10.97 | 10.92 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 2.54 | 2.02 | 1.92 | 1.32 | 1.95 | |
| PBDIT/Share (Rs.) | 0.81 | 0.85 | 0.57 | 0.38 | 0.15 | |
| PBIT/Share (Rs.) | 0.43 | 0.58 | 0.28 | 0.09 | -0.12 | |
| PBT/Share (Rs.) | 0.38 | -0.04 | 0.25 | 0.05 | -0.15 | |
| Net Profit/Share (Rs.) | 0.12 | -0.09 | 0.17 | 0.04 | -0.17 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 31.68 | 41.94 | 29.52 | 28.87 | 7.79 | |
| PBIT Margin (%) | 16.85 | 28.49 | 14.44 | 6.90 | -5.92 | |
| PBT Margin (%) | 14.83 | -2.09 | 13.04 | 3.45 | -7.90 | |
| Net Profit Margin (%) | 4.63 | -4.45 | 8.76 | 3.37 | -8.75 | |
| Return on Networth / Equity (%) | 1.05 | -0.81 | 1.51 | 0.40 | -1.56 | |
| Return on Capital Employed (%) | 0.81 | -0.64 | 1.18 | 0.31 | -1.19 | |
| Return on Assets (%) | 0.77 | -0.62 | 1.12 | 0.29 | -1.13 | |
| Total Debt/Equity (X) | 0.30 | 0.26 | 0.28 | 0.32 | 0.34 | |
| Asset Turnover Ratio (%) | 16.72 | 13.93 | 12.86 | 8.87 | 12.91 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 8.65 | 13.22 | 13.57 | 13.99 | 11.49 | |
| Quick Ratio (X) | 8.65 | 13.22 | 13.57 | 13.99 | 11.49 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 0.00 | 100.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 0.00 | 100.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3.65 | 2.66 | 5.36 | 2.99 | 4.04 | |
| EV/Net Operating Revenue (X) | 3.98 | 3.66 | 7.75 | 6.27 | 5.74 | |
| EV/EBITDA (X) | 12.57 | 8.74 | 26.26 | 21.71 | 73.70 | |
| MarketCap/Net Operating Revenue (X) | 2.95 | 2.85 | 6.55 | 4.09 | 4.10 | |
| Retention Ratios (%) | 100.00 | 0.00 | 100.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.67 | 0.52 | 1.13 | 0.49 | 0.73 | |
| Price/Net Operating Revenue | 2.95 | 2.85 | 6.55 | 4.09 | 4.10 | |
| Earnings Yield | 0.02 | -0.02 | 0.01 | 0.01 | -0.02 |
14.11.2025
Relic Life Scie Consolidated September 2025 Net Sales at Rs 0.60 crore, down 5.44% Y-o-Y
29.07.2025
Relic Life Scie Consolidated June 2025 Net Sales at Rs 1.28 crore, up 214.94% Y-o-Y
03.06.2025
Relic Life Scie Consolidated March 2025 Net Sales at Rs 0.47 crore, up 22.43% Y-o-Y
28.05.2025
Relic Life Scie Standalone March 2025 Net Sales at Rs 0.16 crore, down 59.42% Y-o-Y
14.11.2025
Relic Life Scie Consolidated September 2025 Net Sales at Rs 0.60 crore, down 5.44% Y-o-Y
29.07.2025
Relic Life Scie Consolidated June 2025 Net Sales at Rs 1.28 crore, up 214.94% Y-o-Y
03.06.2025
Relic Life Scie Consolidated March 2025 Net Sales at Rs 0.47 crore, up 22.43% Y-o-Y
28.05.2025
Relic Life Scie Standalone March 2025 Net Sales at Rs 0.16 crore, down 59.42% Y-o-Y
28.05.2024
28.05.2024
Bulk deals: Kotak Mahindra MF buys 3.86% in Prudent Corporate Advisory Services
27.05.2024
29.04.2024
Buy UTI Asset Management Company; target of Rs 1050: Prabhudas Lilladher